Overexpression of p185 is not related to erbB2 amplification in ovarian cancer

Autor:	Morali, F, Cattabeni, M, Tagliabue, E, Campiglio, M, Menard, S, Marzola, M, Lucchini, V, Mangioni, C, Redaelli, L., COLOMBO, NICOLETTA
Přispěvatelé:	Morali, F, Cattabeni, M, Tagliabue, E, Campiglio, M, Menard, S, Marzola, M, Lucchini, V, Colombo, N, Mangioni, C, Redaelli, L
Jazyk:	angličtina
Rok vydání:	1993
Předmět:	Proto-Oncogene Protein Receptor erbB-2 Gene Expression Regulation Ovarian Neoplasm MED/40 - GINECOLOGIA E OSTETRICIA Gene Amplification Humans Female Proto-Oncogene Receptor Epidermal Growth Factor RNA Messenger Neoplasm Staging
Popis:	While in breast cancer the amplification and overexpression of the erbB2 gene has been reported in numerous studies and found to be correlated to poor prognosis, information about this oncogene with respect to ovarian cancer is still limited. A recent study reported that approximately 30% of tumor biopsies from ovarian cancer patients exhibited erbB2 amplification and overexpression and suggested that the overexpression of this oncogene is an indicator of bad prognosis in ovarian cancer. The purpose of our studies was to investigate amplification of the erbB2 gene, the levels of erbB2 m-RNA and the erbB2 product (p185) in ovarian cancer, and the correlation between these findings and the pathological and clinical features.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1299::613724a9bfe681a209ac7366fd1d848a http://hdl.handle.net/10281/27487 Zobrazit plný text záznamu